George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Gix
Surely by now the transition issues have settled down re paperwork/supply chain so there really is NO reason for Healthspan to run out - after all they were third (?) after Sirco and Swansons to take up FF and have repeat orders to fill to the likes of DP.
Is IF prioritizing FF to new, non DSM, customers ? as we get more per serving with them. Are we seeing a ruthless side of him ?
W--anyone's-guess-as-exactly-what-IF-is-up-to--At-least-no-dilution-or-bailing-by-DSM-$
Absolutely. If all UK sales were direct from Provexis, we'd see a big addition to gross profits.
And cheaper. Also give PXS more profit
Why don't you order direct from PXS? :Delivered on time each month
Not sure why you automatically think that Healthspan being out of stock on one of their products is IF's problem.
Could be plenty of reasons why circulease is out of stock other than FF related.
I also did not receive my monthly packet. So what is happening now? Hope of our very good friend IF is doing something so that it will not out of stock for a long time.
Https://www.healthspan.co.uk/circulease-with-150mg-of-fruitflow/#
out of stock
No
I wonder if HMOs have ff in them ! The research study is at the bottom of this page . https://www.dsm.com/human-nutrition/en/products/hmos/hmos-for-gut-health.html
Doesn’t look like SL or DSM have reduced their holding ! Updated 21st July ....https://www.provexis.com/shareholder-information/major-shareholders/
To be fair the brochure doesn't mention any of their gut health ingredients by name.
Maybe it’s part of this . ..https://www.dsm.com/corporate/searchresults.html?query=Fruitflow+microbiota&pageNum=1&languageCode=en&siteName=corporate&filtersRequired=pageKeyWords
Health From The Gut doesn’t seem to include FF.
https://www.dsm.com/content/dam/dsm/human-nutrition/pdfs/aw-100897-dsm-hfg-brochure.pdf
When are we going to see this above 1p 🎻😁😁😭
"when are we going to learn more?"
If not before then by the end of September.
And this part:
The outsourced manufacturer of Fruitflow II SD (Fruitflow in spray dried powder form, the primary form of Fruitflow which is sold) is currently running some long-term stability tests on the product, with a possible view to an extension to the product's existing approved shelf life, and the results of these tests are expected in the coming weeks.
Since this statement................when are we going to learn more? Surely it's imperative we are updated on sales/cash position, when they advised it was so critical
The Company will be in a better position to judge how best to manage its future inventory requirements (which can be met from either: (i) DSM's existing Fruitflow inventory; or (ii) a new Fruitflow production run) in the coming weeks once it has a clearer picture of: (i) the likely demand from the Company's actual and prospective Fruitflow customers for the next 12 months and beyond, to include By-Health; and (ii) the outcome of the stability tests on the existing Fruitflow inventory. The Company is therefore currently seeking to negotiate an extension to the initial three month inventory handover period with DSM. While these negotiations progress the Company will receive incoming funds from further sales of the Company's existing Fruitflow inventory.
The Company remains in negotiations with a third party which might be able to hold inventory for the Company on a consignment basis, with the Company potentially only paying for the inventory when it is required for sale.
Based on the Company's current level of cash it continues to be expected that the Group will need to raise further equity finance, or potentially new loan finance, in the coming months. Considering the success of previous fundraisings and the current performance of the business, the Directors continue to have a reasonable expectation of raising sufficient additional equity capital or new loan finance.
I cannot access BH.
Bodes well for pxs if we can get some products launched in China , I can’t get onto the By health site either
"Ping An Health and By-Health reached a strategic cooperation to promote the innovation of the "commodity + health management service" model"
"This strong alliance between the two parties is expected to combine BY-HEALTH's scientific products with Ping An Health's health management services, give full play to the advantages of the "commodity + service" innovative model, meet the comprehensive health needs of users, and help improve the health literacy level of the whole people."
https://www.pagd.net/allPage/sustainableDevelopment/article?lang=EN_US&id=100624
About Ping An Healthcare and Technology Company Limited.
"Ping An Health had nearly 43 million cumulative paying users and cumulatively served 978 enterprises as of 31 December 2022. The Company has built a team of over 49,000 in-house and external doctors in 23 practices, and signed up more than 2,000 renowned external doctors. Moreover, the Company has over 5,000 partner hospitals, and 224,000 partner pharmacies with a national coverage of over 35%. The Company has enabled 1-hour drug delivery service in 216 cities and 24/7 drug delivery service in 88 cities. In addition, Ping An Health has over 100,000 partner healthcare service providers, and over 2,000 health checkup partners in over 300 cities across the country."
https://www.pagd.net/allPage/aboutUs?lang=EN_US
Can anyone get onto By-Health's website. Seems to have been down for a few days (for me anyway).
both by-health.com and by-health.com.cn
Sphinx, I think you are comparing apples with oranges on this one.
An agreement between Firmenich and Optibiotix cannot be compared with an agreement between DSM and Provexis. DSM and Firmenich merged after the Optibiotix agreement with Firmenich so to say Opti was treated better than PXS is IMO irrelevant and a guess as neither agreement is known in full.
It seems that pxs share of the AA agreement could have been as low as 5% , which makes taking over production even more of a no brainer ! Imho
An agreement was signed with Firmenich in July 2022 to optimise scale up and development of another type of SweetBiotix®. They will pay OptiBiotix a six figure payment per market approval (USA/Europe/Asia) plus royalties and additional milestones on sales. As previously disclosed, Firmenich are one of the world leaders in taste and the world's largest stevia supplier. Their turnover is around £3.6bn per year which has risen to US $11.4bn annual turnover following their merger with DSM, and are now known as DSM Firmenich. They are experts in their field and chose SweetBiotix® after an 18 month due diligence process. This agreement with one of the leaders in the field after extensive due diligence of the science, taste, and intellectual property, is a substantial validation of the SweetBiotix® science and commercial potential.
Our products are also tested by different academic groups providing an independent assessment of their taste and prebiotic functionality. The most recent peer reviewed publication (see Prebiotic Potential of a New Sweetener Based on Galactooligosaccharides and Modified Mogrosides - PubMed (nih.gov)) in a respected industry journal concluded 'These substrates could be considered as novel candidate prebiotic sweeteners, foreseeing a feasible and innovative approach targeting the sucrose content reduction in food. This new ingredient could provide health benefits when evaluated in human studies by combining sweetness and prebiotic fibre functionality'.This is interesting and frustrating that they treated this company (opti) so much better than they have treated pxs , but note they only paid opti 5% of profit ,but a large upfront payment of 6 figures .
Relief capsules still showing out of stock. Don't think its been in stock yet tbh
https://bluetoadbotanicals.com/product/migraine-relief-capsules/
UpSpring fertility was a strange one as it was only ever available in europe on Amazon and never on the US website. I always had a feeling that this was a test product from Reckitt Benckiser.
https://myupspring.com/collections/all
https://www.reckitt.com/media-landing/press-releases/2019/rb-acquires-upspring-an-innovative-pre-and-post-natal-health-company/